N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide
N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide(134742-19-1)
- Name: N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide
- Synonyms:NSC 639829
- Molecular Formula:C21H20 Br N5 O3
- Molecular Weight:470.32
- CAS Registry Number:134742-19-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.134742-19-1 Benzamide,N-[[[4-[(5-bromo-2-pyrimidinyl)oxy]-3-methylphenyl]amino]carbonyl]-2-(dimethylamino)-
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.134742-19-1 134742-19-1
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.134742-19-1 N-[4-(5-Bromo-2-pyrimidinyloxy)-3-methylphenyl]-N'-[2-(dimethylamino)benzoyl]urea
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 24067-77-4/Benzoic acid,3,5-dichloro-4-ethoxy-, 2-(phenylmethyl)hydrazide, hydrochloride (1:1)
- 21231-44-7/ethyl 2-(2-oxo-2H-indol-3-yl)hydrazinecarboxylate
- 168972-17-6/Cyclo[N-methyl-L-alanyl-b-alanyl-(2R)-2-hydroxy-4-methylpentanoyl-(3S)-3-methyl-L-prolyl-L-isoleucyl-N-methyl-L-valyl]
- 14926-08-0/MAGNESIUM-P-AMINOBENZOATE
- 36017-61-5/Pteleoline
- 40138-16-7/2-Formylbenzeneboronic acid
- 60784-31-8/(Z)-non-2-enal
- 10058-92-1/sodium; 2-methoxy-4-nitro-benzenediazonium; 5-sulfonaphthalene-1-sulfonate
- 97986-94-2/4-18-Atrial natriuretic peptide-21 (human reduced),N-(8-amino-1-oxooctyl)-,cyclic (18f4)-peptide
- 94134-61-9/formic acid, compound with N-[3-[(3-aminopropyl)amino]propyl]stearamide (1:1)
- 134721-81-6/2-((4-Methylphenyl)amino)-4-quinolinecarboxylic acid 2-(4-morpholinylacetyl)hydrazide
- 64011-63-8/2-[[(4-Methylcyclohexyl)azo]thio]ethanamine
- 6109-75-7/N,N,N-trimethylpent-4-en-1-aminium iodide
- 68797-62-6/Stearic acid, urea, diethanolamine soap
- 20059-73-8/4-[2-(DIMETHYLAMINO)ETHOXY]BENZYLAMINE
- 28867-18-7/[5-[(dibutylamino)methyl]-1,2,5-trimethyl-4-phenyl-4-piperidyl] propanoate dihydrochloride
- 747-23-9/Oradone
- 37660-22-3/6-amino-2-(ethylthio)-1H-pyrimidin-4-one
- 122055-52-1/Diazene,1,2-bis[4-(hexyloxy)phenyl]-, 1-oxide, (1Z)-
- 134742-19-1/N-[[4-(5-bromopyrimidin-2-yl)oxy-3-methyl-phenyl]carbamoyl]-2-dimethyl amino-benzamide
- 88524-54-3/(5Z,7R,9Z,14bS)-7-Formyl-1,2,4,7,8,10-hexahydro-7-methyl-15-oxo-3,14b-methanoazacycloundecino[5,4-b]indole-9-carboxylic acid methyl ester
- 5625-44-5/cyclo(valylvalyl)
- 12794-09-1/Threomycin (9CI)
- 90605-12-2/Phosphoric acid, 2-methylpropyl ester, ammonium salt
- 145819-92-7/[[[(2R,5S)-5-(4-amino-5-fluoro-2,6-dioxo-3H-pyrimidin-1-yl)-1,3-oxathi olan-2-yl]methyl-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphon ic acid
- 21303-48-0/6-chloro-5-methoxy-3-[2-(2-nitrophenyl)hydrazino]-2H-indol-2-one
- 1253-47-0/4-Methoxycarbonyl-benzyltriphenylphosphoniumchloride
- 78308-56-2/3-(3-chloro-2-methylphenyl)-2-ethylquinazolin-4(3H)-one hydrochloride (1:1)
- 12125-08-5/AMMONIUM HEXACHLOROOSMATE(IV)
- 16958-85-3/2-ETHYLHEXYL PALMITATE